Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer
Fangdie Ye, Yun Hu, Jiahao Gao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Introduction to radiomics for a clinical audience
Cathal McCague, Syafiq Ramlee, Marika Reinius, et al.
Clinical Radiology (2023) Vol. 78, Iss. 2, pp. 83-98
Open Access | Times Cited: 63
Roles and therapeutic implications of m6A modification in cancer immunotherapy
Juan Pan, Tuxiong Huang, Zhenjun Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer
Songwei Feng, Tianyi Xia, Yu Ge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma
Sheng Wu, Xiangkang Lv, Yilin Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 25
Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing
Dong Xu, Kaige Huang, Yang Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Multi-omics analysis defines a cuproptosis-related prognostic model for ovarian cancer: Implication of WASF2 in cuproptosis resistance
Kunyu Wang, Yanan Zhang, Miao Ao, et al.
Life Sciences (2023) Vol. 332, pp. 122081-122081
Open Access | Times Cited: 11
Towards interpretable imaging genomics analysis: Methodological developments and applications
Xiaoping Cen, Wei Dong, Wei Lv, et al.
Information Fusion (2023) Vol. 102, pp. 102032-102032
Closed Access | Times Cited: 11
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
Qiang Liu
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 17
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non‐Invasive Precision Medicine in Cancer Patients
Yusheng Guo, Tianxiang Li, Bingxin Gong, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer
Shenghua Liu, Haotian Chen, Zongtai Zheng, et al.
Bioengineering (2023) Vol. 10, Iss. 3, pp. 318-318
Open Access | Times Cited: 8
Identification of RNA methylation-related lncRNAs for prognostic assessment and immunotherapy in bladder cancer—based on single cell/Bulk RNA sequencing data
LianMing Fan, Jie Wang, Zhiya Zhang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Sandy Figiel, Anthony S. Bates, David A. Braun, et al.
European Urology (2024) Vol. 87, Iss. 1, pp. 8-14
Open Access | Times Cited: 2
Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy
Weiwei Liu, Chaoqun Liu, Hui Wang, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5150-5161
Open Access | Times Cited: 10
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer
Tianming Shi, Ruiqian Yan, M I Han
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 591-604
Open Access | Times Cited: 6
A Risk Score Based on Immune- and Oxidative Stress-Related LncRNAs Predicts Prognosis in Lung Adenocarcinoma: Insights from in vitro Experiments and Large-Scale Transcriptome Analysis
Xin Liu, Fangchao Zhao, Xiaodan Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1453-1465
Open Access | Times Cited: 1
Exploration of immune cell heterogeneity by single‐cell RNA sequencing and identification of secretory leukocyte protease inhibitor as an oncogene in pancreatic cancer
Bolun Ai, Yicheng Liang, Tao Yan, et al.
Environmental Toxicology (2024)
Closed Access | Times Cited: 1
Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration
Yuanliu Nie, Guangyue Yao, Xiao‐Ying Xu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions
Niall J. O’Sullivan, Michael E. Kelly
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4936-4945
Open Access | Times Cited: 3
COL3A1‐positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL–PI3K–AKT axis
Moyan Zhang, Yicheng Liang, Peng Song
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Identification of a novel signature based on M6a modification regulators related LncRNA for stratification of the prognosis of prostate cancer
S. Wang, Xianghui Xie
Environmental Toxicology (2023) Vol. 39, Iss. 4, pp. 2340-2349
Closed Access | Times Cited: 3
Pathological images for personal medicine in Hepatocellular carcinoma: Cross-talk of gene sequencing and pathological images
Yang Li, Kun Deng, ZHIQIANG MOU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2022) Vol. 30, Iss. 5, pp. 243-258
Open Access | Times Cited: 5
What Genetics Can Do for Oncological Imaging: A Systematic Review of the Genetic Validation Data Used in Radiomics Studies
Rebeca Mirón Mombiela, Anne Rix Arildskov, Frederik Jager Bruun, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6504-6504
Open Access | Times Cited: 3
Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer
Xuliren Wang, Fangdie Ye, Min Xiong, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
A novel cervix carcinoma biomarker: Pathological-epigenomics, integrated analysis of MethylMix algorithm and pathology for predicting response to cancer immunotherapy
Yu-Chong Yu, Tianming Shi, Shenglan Gu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Research Progress of New Urine Markers in the Diagnosis of Bladder Cancer
Rose Lamichhane
annals of urologic oncology (2024)
Open Access
Page 1 - Next Page

Scroll to top